rs1060503452

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_000719.7(CACNA1C):​c.1337A>G​(p.Asp446Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D446H) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

CACNA1C
NM_000719.7 missense

Scores

13
3
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.05

Publications

4 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.889

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.1427A>G p.Asp476Gly missense_variant Exon 9 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.1427A>G p.Asp476Gly missense_variant Exon 9 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.1427A>G p.Asp476Gly missense_variant Exon 9 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.1427A>G p.Asp476Gly missense_variant Exon 9 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.1427A>G p.Asp476Gly missense_variant Exon 9 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.1427A>G p.Asp476Gly missense_variant Exon 9 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.1328A>G p.Asp443Gly missense_variant Exon 9 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.1337A>G p.Asp446Gly missense_variant Exon 9 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.1113+19545A>G intron_variant Intron 7 of 26 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Long QT syndrome Uncertain:1
Apr 07, 2016
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a CACNA1C-related disease. This sequence change replaces aspartic acid with glycine at codon 446 of the CACNA1C protein (p.Asp446Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
CardioboostArm
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.47
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.080
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Pathogenic
0.70
D
MetaRNN
Pathogenic
0.89
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.7
.;H;.;H;H;H;H;H;H;H;H;H;H;H;H;H;.;H;H;H;.;.;.
PhyloP100
6.1
PrimateAI
Pathogenic
0.83
D
PROVEAN
Pathogenic
-5.3
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
0.88
Sift
Uncertain
0.0020
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
0.0040
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0, 1.0, 0.91, 1.0
.;D;.;D;D;P;D;D;D;D;D;D;D;D;D;D;.;D;D;.;.;.;D
Vest4
0.71
MutPred
0.30
Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);Gain of catalytic residue at P449 (P = 0.0057);
MVP
0.93
MPC
2.5
ClinPred
1.0
D
GERP RS
4.4
gMVP
0.91
Mutation Taster
=12/88
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060503452; hg19: chr12-2622097; API